A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts
通过6位分析师一窥Pacira BioSciences的专家展望
Across the recent three months, 6 analysts have shared their insights on Pacira BioSciences (NASDAQ:PCRX), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，有6位分析师分享了他们对Pacira BioSciences（纳斯达克股票代码：PCRX）的见解，表达了从看涨到看跌的各种观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $49.0, a high estimate of $57.00, and a low estimate of $45.00. Highlighting a 7.55% decrease, the current average has fallen from the previous average price target of $53.00.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为49.0美元，最高估计为57.00美元，低估值为45.00美元。当前的平均价格已从之前的平均目标价53.00美元有所下降，这凸显了7.55％的跌幅。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
An in-depth analysis...
对分析师...
登录免费看全文
登录/注册